The University of Texas M. D. Anderson Cancer Center is proposing a Specialized Program of Research Excellence (SPORE) in head and neck cancer. The primary goal of this research program is to cultivate and facilitate innovative and significant translational research in the biologic, genetic and clinical aspects of early detection, prevention and treatment of head and neck cancer. These efforts will lead to changes in clinical practice that favorably impact mortality and morbidity of patients with cancer and decrease the incidence of head and neck cancer. The multidisciplinary group of distinguished investigators assembled for this research program will accomplish this goal through effective and collaborative integration of laboratory, epidemiologic and clinical investigations. Such activity will further our understanding of genetic susceptibility and the tumorigenic process in target tissue, leading to novel, molecularly-targeted strategies for the treatment and prevention of head and neck cancer. As outlined below, the program is designed with five research projects and three core resources, as well as programs for developmental research and career development. The research projects are designed to target specific areas important in head and neck cancer, as well as cancers at other disease sites. Project 1: Genetic Susceptibility Markers in Surrogate and Target Tissues Project 2: Targeting Angiogenesis for Therapy of Head and Neck Cancer Project 3: Targeting EGFR for Chemoprevention of Head and Neck Cancer Project 4: Targeting the p53 Pathway for Reversal of Oral Premalignancy Project 5: Targeting Induction of Apoptosis for Therapy of Head and Neck Cancer Core : Biostatistics and Data Management Core : Tissue Procurement and Pathology Developmental Research Program and Career Development Program Through this research program, our research team will make a significant impact on prevention and clinical care of patients with head and neck cancer. We will bring all of our resources to bear on this problem.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
3P50CA097007-05S2
Application #
7488146
Study Section
Special Emphasis Panel (ZCA1-SRRB-E (M1))
Program Officer
Ujhazy, Peter
Project Start
2002-09-30
Project End
2008-07-31
Budget Start
2006-09-22
Budget End
2008-07-31
Support Year
5
Fiscal Year
2007
Total Cost
$750,000
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Surgery
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
(2018) Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 50:668-681
Jurkovic, Ines-Ana; Kocak-Uzel, Esengul; Mohamed, Abdallah Sherif Radwan et al. (2018) Dosimetric and Radiobiological Evaluation of Patient Setup Accuracy in Head-and-neck Radiotherapy Using Daily Computed Tomography-on-rails-based Corrections. J Med Phys 43:28-40
Huckins, L M; Hatzikotoulas, K; Southam, L et al. (2018) Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa. Mol Psychiatry 23:1169-1180
M. D. Anderson Cancer Center Head and Neck Quantitative Imaging Working Group (2018) Investigation of radiomic signatures for local recurrence using primary tumor texture analysis in oropharyngeal head and neck cancer patients. Sci Rep 8:1524
Gadhikar, Mayur A; Zhang, Jiexin; Shen, Li et al. (2018) CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition. Cancer Res 78:781-797
Zhang, Tongwu; Choi, Jiyeon; Kovacs, Michael A et al. (2018) Cell-type-specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes. Genome Res 28:1621-1635
Saintigny, Pierre; Mitani, Yoshitsugu; Pytynia, Kristen B et al. (2018) Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Cancer 124:3693-3705
Pinnix, Chelsea C; Ng, Andrea K; Dabaja, Bouthaina S et al. (2018) Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL. Blood Adv 2:1334-1343
Kamal, Mona; Ng, Sweet Ping; Eraj, Salman A et al. (2018) Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol 79:1-8
Grossberg, Aaron J; Mohamed, Abdallah S R; Elhalawani, Hesham et al. (2018) Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Sci Data 5:180173

Showing the most recent 10 out of 370 publications